NCT04951154 2025-08-19
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
Janssen Research & Development, LLC
Completed
Clinical Trials
29 trialsNCT05962905 2025-05-09
INCATH
Medtronic - MITG
Completed
NCT02274662 2025-01-16
Expanded Access Protocol Thymus Transplantation
Sumitomo Pharma Switzerland GmbH
Phase 4 Completed
NCT06738511 2024-12-17
Validation of a Molecular Signature for Early Detection of Colorectal Cancer
ADVANCED MARKER DISCOVERY S.L.
Phase NA Completed
NCT03259230 2024-09-19
Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Swedish Orphan Biovitrum
Completed
NCT04180176 2024-01-17
PCG
Genentech, Inc.
Phase 4 Completed
NCT03871816 2023-12-11
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
Janssen Research & Development, LLC
Completed
NCT02121873 2023-07-20
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
Atossa Therapeutics, Inc.
Completed
NCT02781272 2023-06-05
EMBER
Angle plc
Completed
NCT03427450 2023-06-05
HOMING
Angle plc
Completed
NCT04264767 2022-06-08
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA
Nucleix Ltd.
Completed
NCT02376296 2022-02-17
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Saladax Biomedical, Inc.
Completed
NCT04515043 2021-06-01
EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)
Invectys
Phase 1 Completed
NCT03355820 2020-11-19
A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study
GlaxoSmithKline
Phase 3 Completed
NCT00947115 2020-10-30
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
GlaxoSmithKline
Phase 3 Completed
NCT03706235 2020-07-14
NOVA
Clinical Genomics Pathology
Completed
NCT03078036 2020-05-20
BREAKOUT
AstraZeneca
Completed
NCT03706248 2020-02-13
PASCAL
Clinical Genomics Pathology
Completed
NCT00877877 2020-01-18
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
GlaxoSmithKline
Phase 3 Completed
NCT02785731 2018-11-09
Evaluation of Multiple Biomarkers to Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Angle plc
Completed
NCT01701050 2017-03-08
COMETI P2
Janssen Diagnostics, LLC
Completed
NCT00518336 2016-12-09
Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
GlaxoSmithKline
Phase 2 Completed
NCT00929526 2016-10-20
Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study
GlaxoSmithKline
Phase 3 Completed
NCT01071837 2015-06-16
APG101 in Glioblastoma
Apogenix AG
Phase 2 Completed
NCT02016833 2015-04-30
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
Completed
NCT00855348 2014-08-04
PRESEPT
Epigenomics, Inc
Completed
NCT01329718 2014-08-04
SPR0012
Epigenomics, Inc
Phase EARLY_PHASE1 Completed
NCT00436189 2008-04-30
Assess Cancer in Ovarian Tumors With Biomarkers.
Ciphergen Biosystems
Phase NA Completed
NCT00140036 2008-03-03
Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).
Pfizer
Phase 4 Completed